Cortexyme Appoints June Bray to its Board of Directors : vim

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company...

Related Keywords

June Bray , David Lamond , Stacy Roughan , Cortexyme Inc , Corporate Communications Investor Relations , Nasdaq , Hoechst Roussel Pharmaceuticals , University Of Rhode Island , Allergan , Bayer Healthcare Pharmaceuticals , Fairleigh Dickinson University , Regulatory Affairs At Organon , Berlex Laboratories Inc , Global Regulatory Affairs , Cortexyme Board , Senior Vice President , Medical Writing , Vice President , Regulatory Affairs , Berlex Laboratories , Rhode Island , Pharmaceutical Marketing , Fairleigh Dickinson , Corporate Communications ,